736 related articles for article (PubMed ID: 18218660)
21. Correlation analysis between echocardiographic flow pattern and N-terminal-pro-brain natriuretic peptide for early targeted treatment of patent ductus arteriosus.
Occhipinti F; De Carolis MP; De Rosa G; Bersani I; Lacerenza S; Cota F; Rubortone SA; Romagnoli C
J Matern Fetal Neonatal Med; 2014 Nov; 27(17):1800-4. PubMed ID: 24397409
[TBL] [Abstract][Full Text] [Related]
22. Diagnosing significant PDA using natriuretic peptides in preterm neonates: a systematic review.
Kulkarni M; Gokulakrishnan G; Price J; Fernandes CJ; Leeflang M; Pammi M
Pediatrics; 2015 Feb; 135(2):e510-25. PubMed ID: 25601976
[TBL] [Abstract][Full Text] [Related]
23. Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.
Koch AM; Rauh M; Zink S; Singer H
Acta Paediatr; 2006 Jul; 95(7):805-9. PubMed ID: 16801175
[TBL] [Abstract][Full Text] [Related]
24. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
25. Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus.
Harris SL; More K; Dixon B; Troughton R; Pemberton C; Horwood J; Ellis N; Austin N
Eur J Pediatr; 2018 Apr; 177(4):521-532. PubMed ID: 29352349
[TBL] [Abstract][Full Text] [Related]
26. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
27. N-terminal pro-brain natriuretic peptide used for the prediction of coronary artery stenosis.
Wolber T; Maeder M; Rickli H; Riesen W; Binggeli C; Duru F; Ammann P
Eur J Clin Invest; 2007 Jan; 37(1):18-25. PubMed ID: 17181563
[TBL] [Abstract][Full Text] [Related]
28. Midregional pro-atrial natriuretic peptide is a useful indicator for the detection of impaired left ventricular function in patients with coronary artery disease.
Elmas E; Brueckmann M; Lang S; Kälsch T; Haghi D; Sueselbeck T; Dempfle CE; Borggrefe M
Int J Cardiol; 2008 Aug; 128(2):244-9. PubMed ID: 17673312
[TBL] [Abstract][Full Text] [Related]
29. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements.
Tschöpe C; Kasner M; Westermann D; Gaub R; Poller WC; Schultheiss HP
Eur Heart J; 2005 Nov; 26(21):2277-84. PubMed ID: 16014646
[TBL] [Abstract][Full Text] [Related]
30. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
[TBL] [Abstract][Full Text] [Related]
31. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
32. Utility of N-terminal pro-brain natriuretic peptide for assessing hemodynamic significance of patent ductus arteriosus in dogs undergoing ductal repair.
Hariu CD; Saunders AB; Gordon SG; Norby B; Miller MW
J Vet Cardiol; 2013 Sep; 15(3):197-204. PubMed ID: 23933478
[TBL] [Abstract][Full Text] [Related]
33. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation.
Weber M; Hausen M; Arnold R; Moellmann H; Nef H; Elsaesser A; Mitrovic V; Hamm C
Int J Cardiol; 2008 Jul; 127(3):321-7. PubMed ID: 18055041
[TBL] [Abstract][Full Text] [Related]
35. Comparison of N-terminal pro-B-type natriuretic peptide levels in critically ill children with sepsis versus acute left ventricular dysfunction.
Fried I; Bar-Oz B; Algur N; Fried E; Gavri S; Yatsiv I; Perles Z; Rein AJ; Zonis Z; Bass R; Nir A
Pediatrics; 2006 Oct; 118(4):e1165-8. PubMed ID: 16966393
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
[TBL] [Abstract][Full Text] [Related]
37. Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease.
Grasso S; Leone A; De Michele M; Anaclerio R; Cafarelli A; Ancona G; Stripoli T; Bruno F; Pugliese P; Dambrosio M; Dalfino L; Di Serio F; Fiore T
Crit Care Med; 2007 Jan; 35(1):96-105. PubMed ID: 17095948
[TBL] [Abstract][Full Text] [Related]
38. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
[TBL] [Abstract][Full Text] [Related]
39. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
Feringa HH; Bax JJ; Elhendy A; de Jonge R; Lindemans J; Schouten O; van den Meiracker AH; Boersma E; Schinkel AF; Kertai MD; van Sambeek MR; Poldermans D
Am J Cardiol; 2006 Jul; 98(1):111-5. PubMed ID: 16784932
[TBL] [Abstract][Full Text] [Related]
40. The role of plasma N-terminal pro-B-type natriuretic peptide in predicting the severity of transient tachypnea of the newborn.
Aydemir O; Aydemir C; Sarikabadayi YU; Altug N; Erdeve O; Uras N; Oguz SS; Dilmen U
Early Hum Dev; 2012 May; 88(5):315-9. PubMed ID: 21955499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
